Magnetic Resonance Macromolecular Agents for Monitoring Tumor Microvessels and Angiogenesis Inhibition
Authors:
- Anda PredaAPAnda Preda
- Marion van VlietMVMarion van Vliet
- Gabriel P. KrestinGKGabriel P. Krestin
- Robert C. BraschRBRobert C. Brasch
- Cornelius F. van DijkeCDCornelius F. van Dijke
- 1 March 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 41 (3) , 325-331
Abstract
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) using macromolecular contrast media enables assessments of the tumor vasculature based on the differential distribution of the contrast agent within normal and pathologic tissues. Quantitative assays of both morphologic and functional properties can provide useful diagnostic insight into tissue angiogenesis. The use of MRI enhanced with macromolecular agents for the characterization of tumor microvessels has been experimentally demonstrated in a range of malignant tumor types. Kinetic analysis of DCE-MRI data can be used to estimate microvascular permeability and tumor blood volume. By measuring these functional tumor properties, an accurate, noninvasive, and quantitative description of the microcirculation of individual tumors can be acquired, improving the specificity of imaging examinations for cancer diagnosis and for treatment and follow up. The noninvasive MRI assessment of tumor angiogenesis can be applied in the diagnostic differentiation between benign and malignant tumors and can also provide means for in vivo monitoring of antitumor therapy. In this review, the potential clinical applications and limitations of various macromolecular contrast agents applied for evaluations of tumor angiogenesis, with and without drug interventions, are discussed.Keywords
This publication has 66 references indexed in Scilit:
- Dynamic Magnetic Resonance Tomography and Proton Magnetic Resonance Spectroscopy of Prostate Cancers in Rats Treated by RadiotherapyInvestigative Radiology, 2004
- “Hands-on” WorkshopsEuropean Radiology, 2003
- Tumor angiogenesis: Molecular pathology, therapeutic targeting, and imagingAcademic Radiology, 2000
- Angiogenesis imagingAcademic Radiology, 2000
- Dynamic Contrast Enhanced MRI of Prostate Cancer: Correlation with Morphology and Tumour Stage, Histological Grade and PSAClinical Radiology, 2000
- Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancerJournal of Magnetic Resonance Imaging, 1999
- Multicompartment analysis of gadolinium chelate kinetics: Blood-tissue exchange in mammary tumors as monitored by dynamic MR imagingJournal of Magnetic Resonance Imaging, 1999
- Quantification of the extraction fraction for gadopentetate across breast cancer capillaries.Magnetic Resonance in Medicine, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Molecular Mechanisms of Developmental and Tumor AngiogenesisBrain Pathology, 1994